12 September 2008
Financing and clinical study enroled
ImVisioN Therapeutics starts Phase I clinical trial of IVN201 against cat dander allergy and raises CHF 4.6 M
latest news
- 19/03/2009
Positive Phase I Clinical Results for Treatment of Cat Dander Allergy... - 10/11/2008
ILIT Proof of Concept published in PNAS... - 12/09/2008
Financing and clinical study enroled... - 06/02/2007
EU patent for MAT™ technology granted ...